Correlation Between NewAmsterdam Pharma and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Cullinan Oncology LLC, you can compare the effects of market volatilities on NewAmsterdam Pharma and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Cullinan Oncology.
Diversification Opportunities for NewAmsterdam Pharma and Cullinan Oncology
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NewAmsterdam and Cullinan is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Cullinan Oncology go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Cullinan Oncology
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 0.72 times more return on investment than Cullinan Oncology. However, NewAmsterdam Pharma is 1.38 times less risky than Cullinan Oncology. It trades about -0.01 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.02 per unit of risk. If you would invest 2,423 in NewAmsterdam Pharma on August 25, 2024 and sell it today you would lose (403.00) from holding NewAmsterdam Pharma or give up 16.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Cullinan Oncology LLC
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Cullinan Oncology LLC |
NewAmsterdam Pharma and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Cullinan Oncology
The main advantage of trading using opposite NewAmsterdam Pharma and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. HCW Biologics | Cullinan Oncology vs. RenovoRx | Cullinan Oncology vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |